Literature DB >> 23764196

NIMROD: a program for inference via a normal approximation of the posterior in models with random effects based on ordinary differential equations.

Mélanie Prague1, Daniel Commenges, Jérémie Guedj, Julia Drylewicz, Rodolphe Thiébaut.   

Abstract

Models based on ordinary differential equations (ODE) are widespread tools for describing dynamical systems. In biomedical sciences, data from each subject can be sparse making difficult to precisely estimate individual parameters by standard non-linear regression but information can often be gained from between-subjects variability. This makes natural the use of mixed-effects models to estimate population parameters. Although the maximum likelihood approach is a valuable option, identifiability issues favour Bayesian approaches which can incorporate prior knowledge in a flexible way. However, the combination of difficulties coming from the ODE system and from the presence of random effects raises a major numerical challenge. Computations can be simplified by making a normal approximation of the posterior to find the maximum of the posterior distribution (MAP). Here we present the NIMROD program (normal approximation inference in models with random effects based on ordinary differential equations) devoted to the MAP estimation in ODE models. We describe the specific implemented features such as convergence criteria and an approximation of the leave-one-out cross-validation to assess the model quality of fit. In pharmacokinetics models, first, we evaluate the properties of this algorithm and compare it with FOCE and MCMC algorithms in simulations. Then, we illustrate NIMROD use on Amprenavir pharmacokinetics data from the PUZZLE clinical trial in HIV infected patients.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  HIV; Maximum a posteriori; Maximum likelihood; Non-linear mixed-effects model; Ordinary differential equations; Pharmacokinetics

Mesh:

Substances:

Year:  2013        PMID: 23764196     DOI: 10.1016/j.cmpb.2013.04.014

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  7 in total

1.  The stochastic system approach for estimating dynamic treatments effect.

Authors:  Daniel Commenges; Anne Gégout-Petit
Journal:  Lifetime Data Anal       Date:  2015-02-11       Impact factor: 1.588

2.  Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort Study.

Authors:  Mélanie Prague; Daniel Commenges; Jon Michael Gran; Bruno Ledergerber; Jim Young; Hansjakob Furrer; Rodolphe Thiébaut
Journal:  Biometrics       Date:  2016-07-26       Impact factor: 2.571

3.  Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients.

Authors:  Solène Desmée; France Mentré; Christine Veyrat-Follet; Bernard Sébastien; Jérémie Guedj
Journal:  Biometrics       Date:  2016-05-05       Impact factor: 2.571

4.  Comparison of empirical and dynamic models for HIV viral load rebound after treatment interruption.

Authors:  Ante Bing; Yuchen Hu; Melanie Prague; Alison L Hill; Jonathan Z Li; Ronald J Bosch; Victor De Gruttola; Rui Wang
Journal:  Stat Commun Infect Dis       Date:  2020-08-21

5.  Quantifying and predicting the effect of exogenous interleukin-7 on CD4+ T cells in HIV-1 infection.

Authors:  Rodolphe Thiébaut; Julia Drylewicz; Mélanie Prague; Christine Lacabaratz; Stéphanie Beq; Ana Jarne; Thérèse Croughs; Rafick-Pierre Sekaly; Michael M Lederman; Irini Sereti; Daniel Commenges; Yves Lévy
Journal:  PLoS Comput Biol       Date:  2014-05-22       Impact factor: 4.475

6.  Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation.

Authors:  Chloé Pasin; Irene Balelli; Thierry Van Effelterre; Viki Bockstal; Laura Solforosi; Mélanie Prague; Macaya Douoguih; Rodolphe Thiébaut
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

7.  Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection.

Authors:  Ananya Saha; Narendra M Dixit
Journal:  PLoS Comput Biol       Date:  2020-11-30       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.